David J Yvars Group Makes New $499,000 Investment in Astera Labs, Inc. (NASDAQ:ALAB)

David J Yvars Group bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 3,770 shares of the company’s stock, valued at approximately $499,000.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. FMR LLC boosted its holdings in Astera Labs by 0.7% in the 3rd quarter. FMR LLC now owns 23,504,038 shares of the company’s stock worth $1,231,377,000 after buying an additional 153,491 shares during the last quarter. Fred Alger Management LLC increased its position in shares of Astera Labs by 1,361.0% during the third quarter. Fred Alger Management LLC now owns 2,821,921 shares of the company’s stock worth $147,840,000 after purchasing an additional 2,628,765 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Astera Labs by 3.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,568,314 shares of the company’s stock valued at $82,164,000 after purchasing an additional 47,569 shares during the last quarter. Maverick Capital Ltd. lifted its holdings in Astera Labs by 16.0% in the 3rd quarter. Maverick Capital Ltd. now owns 1,156,230 shares of the company’s stock valued at $60,575,000 after purchasing an additional 159,480 shares in the last quarter. Finally, Westfield Capital Management Co. LP purchased a new stake in shares of Astera Labs during the third quarter worth $52,049,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Down 1.9 %

Astera Labs stock opened at $127.19 on Tuesday. Astera Labs, Inc. has a 52-week low of $36.22 and a 52-week high of $147.39. The company’s 50 day moving average is $116.88 and its two-hundred day moving average is $74.77.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The company had revenue of $113.10 million for the quarter, compared to the consensus estimate of $97.50 million. The company’s revenue for the quarter was up 47.1% on a year-over-year basis. As a group, equities analysts forecast that Astera Labs, Inc. will post -0.45 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on ALAB shares. Barclays upped their price target on Astera Labs from $70.00 to $87.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Roth Mkm increased their price target on shares of Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. Northland Capmk lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Thursday, January 2nd. Finally, JPMorgan Chase & Co. raised their target price on Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, Astera Labs has an average rating of “Moderate Buy” and a consensus price target of $105.75.

Insider Buying and Selling

In other news, Director Manuel Alba sold 11,000 shares of the stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $117.50, for a total value of $1,292,500.00. Following the completion of the sale, the director now directly owns 456,863 shares of the company’s stock, valued at approximately $53,681,402.50. This represents a 2.35 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jitendra Mohan sold 171,064 shares of Astera Labs stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $103.53, for a total transaction of $17,710,255.92. Following the completion of the transaction, the chief executive officer now owns 628,895 shares in the company, valued at approximately $65,109,499.35. This represents a 21.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,690,452 shares of company stock worth $167,581,256 over the last 90 days.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.